Orchestra BioMed Holdings, Inc. (OBIO) Net margin 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) net profit margin by fiscal year — reported net income divided by reported revenue.
-157.4%FY2025 · since FY2022: -951.3% → -157.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -157.4% | +2155.9 pp |
| FY2024 | -2313.3% | -533.6 pp |
| FY2023 | -1779.7% | -828.5 pp |
| FY2022 | -951.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →